Pharmacy Compounding 4

Question 1

A compounder needs to prepare 200 mL of a 2% w/v solution from a 10% w/v stock solution. How many mL of stock solution are needed?

Accepted Answer

40 mL

Answer

10 mL

Answer

20 mL

Answer

50 mL

Question 2

According to USP <797>, Category 1 CSPs (compounded sterile preparations) with no antimicrobial preservative stored at room temperature have a BUD of:

Accepted Answer

24 hours

Answer

12 hours

Answer

48 hours

Answer

72 hours

Question 3

Which type of water is required for preparing compounded sterile preparations (CSPs)?

Accepted Answer

Sterile Water for Injection (WFI)

Answer

Tap water

Answer

Distilled water

Answer

Deionized water

Question 4

When compounding a capsule, what excipient is commonly added as a glidant to improve powder flow?

Accepted Answer

Colloidal silicon dioxide (Cab-O-Sil)

Answer

Magnesium stearate

Answer

Lactose

Answer

Microcrystalline cellulose

Question 5

A pharmacy must conduct media-fill testing when performing sterile compounding. The primary purpose is to:

Accepted Answer

Verify the aseptic technique of the compounder

Answer

Test the potency of the finished product

Answer

Determine the beyond-use date

Answer

Check for endotoxin contamination

Question 6

Which packaging material is preferred for light-sensitive compounded preparations?

Accepted Answer

Amber glass or amber plastic containers

Answer

Clear glass containers

Answer

White HDPE containers

Answer

Stainless steel containers

Question 7

According to USP <800>, which category of hazardous drugs requires full containment controls (C-PEC + C-SEC) even for non-sterile compounding?

Accepted Answer

NIOSH Table 1 antineoplastic drugs

Answer

NIOSH Table 2 drugs only

Answer

NIOSH Table 3 antineoplastic drugs

Answer

All drugs on any NIOSH table